The current price of ERAS is $13.27 — it has decreased by 11.00% since the previous close. Data as of Nov 5, 2026.
ERAS is down 9.48% over the past week, down 7.20% over the past month and up 492.41% over the past year. The price is below its 200-day moving average of $15.08.
Of the 9 analysts covering Erasca, Inc., 2 rate it a strong buy, 5 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Erasca, Inc. has a market capitalization of $4.64B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Erasca, Inc. posted a loss of $0.14 per share against an estimate of -$0.1114, missing expectations by 25.71%. Upcoming reports are listed in the earnings calendar.
In the latest trading session ERAS moved between $13.19 and $15.18, a range of 15.03% of its current price.
Over the past 52 weeks ERAS has traded between $2.11 and $24.28. The current price is 45.35% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.